ETNB - 89bio, Inc. Common Stock -  [ ]

Ticker Details
89bio, Inc. Common Stock
IPO Date: November 19, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $2.2B
Activated in VL: False
Average Daily Range
Avg Daily Range: $0.37 | 3.34%
Avg Daily Range (30 D): $0.02 | 0.16%
Avg Daily Range (90 D): $0.14 | 1.49%
Institutional Daily Volume
Avg Daily Volume: 1.01M
Avg Daily Volume (30 D): 2.97M
Avg Daily Volume (90 D): 3.43M
Trade Size
Avg Trade Size (Sh.): 112
Avg Trade Size (Sh.) (30 D): 372
Avg Trade Size (Sh.) (90 D): 227
Institutional Trades
Total Institutional Trades: 1,741
Avg Institutional Trade: $2.64M
Avg Institutional Trade (30 D): $6.66M
Avg Institutional Trade (90 D): $3.86M
Avg Institutional Trade Volume: .21M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $3.01M
Avg Closing Trade (30 D): $19.72M
Avg Closing Trade (90 D): $6.93M
Avg Closing Volume: 255.76K
 
News
Oct 16, 2025 @ 8:58 PM
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Inve...
Source: Brodsky & Smith
Sep 27, 2025 @ 4:09 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest...
Source: Halper Sadeh Llc
Sep 26, 2025 @ 9:30 PM
$HAREHOLDER ALERT: The M&A Class Action Firm Is In...
Source: Juan Monteverde
Sep 23, 2025 @ 10:30 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest...
Source: Halper Sadeh Llc
Sep 20, 2025 @ 12:49 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest...
Source: Halper Sadeh Llc
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $-.71 $-.49 $-1.39
Diluted EPS $-.71 $-.49 $-1.39
Revenue $M $M $M
Gross Profit
Net Income / Loss $-111.5M $-71.28M $-149.07M
Operating Income / Loss $-115.82M $-75.91M $-151.94M
Cost of Revenue
Net Cash Flow $-186.32M $189.34M $-120.81M
PE Ratio